NEW YORK, May 12, 2010 /PRNewswire/ --
- IntraLinks will Help to Meet the Pharmaceutical Industry's Objective to Move Towards Completely Paperless Clinical Trials
IntraLinks, the leading provider of critical information exchange solutions, today announced a partnership with SAFE-BioPharma, the non-profit association that created and manages the SAFE-BioPharma(R) digital identity and signature standard for the pharmaceutical and healthcare industries. IntraLinks users, which include the top 10 pharmaceutical, biotechnology and contract research organizations (CROs) worldwide, will now be able to use the SAFE-BioPharma digital identity for signing documents. They can increase clinical trial efficiency by signing paperwork with a SAFE credential that provides additional security and speed, eliminating printing of hard copy casebooks and other documents.
IntraLinks provides automated and secure document sharing solutions for the life sciences industry. Its' SaaS-based platform already helps pharmaceutical and clinical and safety teams achieve greater efficiencies, improve regulatory compliance and reduce risk but providing an alternative to the "wet" signature will help to take this to the next level. Users will have the opportunity to securely upload and use their SAFE-BioPharma digital identities on the IntraLinks(R) platform, ensuring that their credentials are available anytime and anywhere via the Web. IntraLinks is also enabling documents signed with SAFE-BioPharma signatures to be stored and shared on its existing platform.
"Incorporating SAFE-BioPharma's digital identity and signature standard
into IntraLinks' platform is very significant for our clients and the
community who rely on IntraLinks to manage their clinical t
Copyright©2010 PR Newswire.
All rights reserved